General Information of Drug (ID: DMBKQ03)

Drug Name
Carpropamid Drug Info
Synonyms
Carpropamid; 104030-54-8; 2,2-Dichloro-N-[1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamide; 2,2-dichloro-N-[1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropane-1-carboxamide; Carpropamid [ISO]; AC1L4B6R; SCHEMBL22262; CHEBI:3434; DTXSID4057922; RXDMAYSSBPYBFW-UHFFFAOYSA-N; KTU-3616; AKOS015888200; Cyclopropanecarboxamide, 2,2-dichloro-N-(1-(4-chlorophenyl)ethyl)-1-ethyl-3-methyl-; AN-34090; TR-000928; Carpropamid, PESTANAL(R), analytical standard; C10932; SR-01000883725; SR-01000883725-1; I01-10136
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
153847
ChEBI ID
CHEBI:3434
CAS Number
CAS 104030-54-8
TTD Drug ID
DMBKQ03

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
(3-Phenyl-propyl)-quinazolin-4-yl-amine DM1C90Y Discovery agent N.A. Investigative [2]
Isoquinolin-1-yl-(3-phenyl-propyl)-amine DMDF26N Discovery agent N.A. Investigative [2]
2-Hydroxy-N-(3-phenyl-propyl)-benzamide DMWSR13 Discovery agent N.A. Investigative [2]
5-Fluoro-2-hydroxy-N-isopropyl-benzamide DMOI7ME Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fungal Scytalone dehydratase (Fung SDH1) TT64EPS SCYD_MAGO7 Inhibitor [1]

References

1 Enzymatic characterization of scytalone dehydratase Val75Met variant found in melanin biosynthesis dehydratase inhibitor (MBI-D) resistant strains of the rice blast fungus. Biosci Biotechnol Biochem.2004 Mar;68(3):615-21.
2 A diazine heterocycle replaces a six-membered hydrogen-bonded array in the active site of scytalone dehydratase, Bioorg. Med. Chem. Lett. 3(8):1605-1608 (1993).
3 Binding dynamics of two water molecules constrained within the scytalone dehydratase binding pocket. Bioorg Med Chem Lett. 2000 Jan 3;10(1):23-6.